Pharmaceutical Analytical Testing Outsourcing Market To Reach $9.6 Billion By 2025: Grand View Research, Inc.
The global pharmaceutical analytical testing outsourcing market is
expected to reach USD 9.6 billion by 2025, according to a new report by Grand
View Research, Inc. The performance of market players in pharmaceutical
analytical testing domain is highly influenced by the level of demand from
end-user side. Due to intense market efforts, increasing awareness level,
improving accessibility, and government initiatives, consumers, these days, are
more concerned about self-care, resulting in higher consumption of
pharmaceutical products.
The consumption levels are
anticipated to rise exponentially over the forecast period. The companies and
government organizations are working collaboratively to bridge the gap between
supply and demand. As a result, companies have to realign their manufacturing
capabilities to meet the increasing demand.
A major price difference between
conducting analytical tests in-house and outsourcing has been observed.
Companies may lack the required set-up and expertise to perform every possible
test in-house. In addition, there are serval no routine activities that are
needed to be performed only once. These include registration stability storage
& testing, process & facility validation work, cleaning validations,
analytical testing using expensive equipment & method development. For such
tests, the best option is to outsource it to a specialty firm that has
expertise and experience in this vertical. Outsourcing benefits companies with
various aspects such as personnel management and reduction of equipment,
validation & maintenance cost.
Browse full research report on Pharmaceutical Analytical
Testing Outsourcing Market: http://www.grandviewresearch.com/industry-analysis/pharmaceutical-analytical-testing-outsourcing-market
Further key findings from
the study suggest:
- The other methods of validation services include
cleaning validation services, analytical standard characterization, and
peak identification. These services are anticipated to witness growth over
the forecast period.
- Clinical bioanalytical testing market is likely to
witness growth rate of over 8.0% during the forecast period owing to the
increasing number of clinical trials coupled with a strengthened
regulatory framework to perform drug discovery and development process at
par with excellence.
- North America is expected to dominate the market at a
global level owing to the better quality and propelling research
activities being conducted within the region.
- Some of the key players in this market include SGS
SA; Toxikon, Inc.; Eurofins Scientific; Pharmaceutical Product
Development, LLC; Intertek Group plc; Pace Analytical Services, LLC; Exova
Group plc; Boston Analytical; Charles River Laboratories International
Inc.; and West Pharmaceutical Services, Inc. Regional & service
portfolio expansions and merger & acquisitions are key strategic
undertakings of these players.
Read Our Blog: http://www.grandviewresearch.com/blog/pharmaceutical-analytical-testing-outsourcing-market-size-share
Grand View Research has segmented the global pharmaceutical
analytical testing outsourcing market on the basis of services and region:
Pharmaceutical Analytical Testing Outsourcing Services
Outlook (Revenue, USD Million, 2014-2025)
- Bioanalytical
Testing
- Clinical
- Non
Clinical
- Method
Development & Validation
- Extractable
& Leachable
- Impurity
Method
- Technical
Consulting
- Others
- Stability
Testing
- Drug
Substance
- Stability
Indicating Method Validation
- Accelerated
Stability Testing
- Phostostability
Testing
- Others
- Others
Pharmaceutical Analytical Testing Outsourcing Services
Regional Outlook (Revenue, USD Million, 2014-2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- Mexico
- Middle
East and Africa (MEA)
- South
Africa
Grand View Research has segmented the bioactive ingredient
market on the basis of product, application and region:
Global Bioactive Ingredients Product Outlook (Revenue,
USD Billion, 2014 - 2024)
- Fiber
- Vitamins
- Omega
3 PUFA
- Plant
extracts
- Minerals
- Carotenoids
& antioxidants
- Probiotics
- Other
types
Global Bioactive Ingredients Application Outlook
(Revenue, USD Billion, 2014 - 2024)
- Functional
food & beverages
- Dietary
supplements
- Clinical
Nutrition
- Personal
care
- Other
products
Global Bioactive Ingredients Regional Outlook (Revenue,
USD Billion, 2014- 2024)
- North
America
- U.S.
- Europe
- Germany
- UK
- France
- Asia
Pacific
- China
- India
- Central
& South America
- Middle
East & Africa
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For more information:
http://www.grandviewresearch.com
Comments
Post a Comment